{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:22:06Z","timestamp":1784809326302,"version":"3.55.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL133589"],"award-info":[{"award-number":["HL133589"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01"],"award-info":[{"award-number":["R01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["ZIADK031117"],"award-info":[{"award-number":["ZIADK031117"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["HHSN-271-2008-00025-C"],"award-info":[{"award-number":["HHSN-271-2008-00025-C"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejmech.2021.113983","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T15:08:10Z","timestamp":1637334490000},"page":"113983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["A3 adenosine receptor agonists containing dopamine moieties for enhanced interspecies affinity"],"prefix":"10.1016","volume":"228","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0932-4143","authenticated-orcid":false,"given":"Dilip K.","family":"Tosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Salmaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan G.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsha","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Bitant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9077-4055","authenticated-orcid":false,"given":"Eline","family":"Pottie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7126-348X","authenticated-orcid":false,"given":"Christophe P.","family":"Stove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naili","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9310-1198","authenticated-orcid":false,"given":"Oksana","family":"Gavrilova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan-Guo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Auchampach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8104-1493","authenticated-orcid":false,"given":"Kenneth A.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113983_bib1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.tips.2016.02.006","article-title":"Adenosine as a multi-signalling guardian angel in human diseases: when, where and how does it exert its protective effects?","volume":"37","author":"Borea","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2021.113983_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000161","article-title":"Physiology and effects of nucleosides in mice lacking all four adenosine receptors","volume":"17","author":"Xiao","year":"2019","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ejmech.2021.113983_bib3","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/med.21456","article-title":"A3 adenosine receptors as modulators of inflammation: from medicinal chemistry to therapy","volume":"38","author":"Jacobson","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2021.113983_bib4","first-page":"87","article-title":"Therapeutic effect of oral CF101 in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled Phase II study","volume":"11","author":"Stoilov","year":"2015","journal-title":"Immunome Res."},{"key":"10.1016\/j.ejmech.2021.113983_bib5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1468-3083.2011.04078.x","article-title":"Treatment of plaque-type psoriasis with oral CF101: data from an exploratory randomized phase 2 clinical trial","volume":"26","author":"David","year":"2012","journal-title":"J.\u00a0Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ejmech.2021.113983_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1634\/theoncologist.2012-0211","article-title":"CF102 for the treatment of hepatocellular carcinoma: a phase I\/II, open-label, dose-escalation study","volume":"18","author":"Stemmer","year":"2013","journal-title":"Oncol."},{"key":"10.1016\/j.ejmech.2021.113983_bib7","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/bph.13446","article-title":"Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics","volume":"173","author":"Janes","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113983_bib8","first-page":"2256","article-title":"The A3 adenosine receptor agonist, namodenoson, ameliorates non-alcoholic steatohepatitis in mice","volume":"44","author":"Fishman","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejmech.2021.113983_bib9","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/med.21456","article-title":"A3 adenosine receptors as modulators of inflammation: from medicinal chemistry to therapy","volume":"38","author":"Jacobson","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2021.113983_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0014-2999(94)90523-1","article-title":"Adenosine A3 receptor stimulation and cerebral ischemia","volume":"263","author":"von Lubitz","year":"1994","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113983_bib11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12974-020-02009-7","article-title":"Adenosine A3 receptor as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury","volume":"17","author":"Farr","year":"2020","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.ejmech.2021.113983_bib12","doi-asserted-by":"crossref","first-page":"694","DOI":"10.18632\/aging.202178","article-title":"Activation of adenosine A3 receptor reduces early brain injury by alleviating neuroinflammation after subarachnoid hemorrhage in elderly rats","volume":"13","author":"Li","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ejmech.2021.113983_bib13","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11302-015-9459-2","article-title":"Efficient, large-scale synthesis and preclinical studies of MRS5698, a highly selective A3 adenosine receptor agonist that protects against chronic neuropathic pain","volume":"11","author":"Tosh","year":"2015","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.ejmech.2021.113983_bib14","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1021\/acs.jmedchem.0c00235","article-title":"Truncated (N)-methanocarba nucleosides as partial agonists at mouse and human A3 adenosine receptors: affinity enhancement by N6-(2-phenylethyl) substitution","volume":"63","author":"Tosh","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113983_bib15","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1021\/jm300396n","article-title":"Structure-guided design of A3 adenosine receptor-selective nucleosides: combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions","volume":"55","author":"Tosh","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113983_bib16","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1126\/science.1202793","article-title":"Agonist bound structure of the human adenosine A2A receptor","volume":"332","author":"Xu","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113983_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuropharm.2016.11.026","article-title":"Hypothermia in mouse is caused by adenosine A1 and A3 receptor agonists and AMP via three distinct mechanisms","volume":"114","author":"Carlin","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2021.113983_bib18","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.drudis.2017.07.013","article-title":"Polypharmacology of conformationally locked methanocarba nucleosides","volume":"22","author":"Jacobson","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2021.113983_bib19","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1021\/acsmedchemlett.9b00637","article-title":"Direct comparison of (N)-methanocarba and ribose-containing 2-arylalkynyladenosine derivatives as A3 receptor agonists","volume":"11","author":"Tosh","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113983_bib20","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1021\/jm4007966","article-title":"Rational design of sulfonated A3 adenosine receptor-selective nucleosides as pharmacological tools to study chronic neuropathic pain","volume":"56","author":"Paoletta","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113983_bib21","series-title":"Abstract, 4th International Symposium of Nucleosides and Nucleotides, Chapel Hill, NC, June 9-11th","article-title":"Pharmacological characterization of recombinant mouse adenosine receptors expressed in HEK 293 cells","author":"Wan","year":"2004"},{"key":"10.1016\/j.ejmech.2021.113983_bib22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11302-015-9460-9","article-title":"Selectivity is species-dependent: characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors","volume":"11","author":"Alnouri","year":"2015","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.ejmech.2021.113983_bib23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nature10136","article-title":"Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation","volume":"474","author":"Lebon","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113983_bib24","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1124\/mol.114.097360","article-title":"Molecular Determinants of CGS21680 binding to the human adenosine A2A receptor","volume":"87","author":"Lebon","year":"2015","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113983_bib25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bcp.2013.10.011","article-title":"Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: insight into the receptor activation switch","volume":"87","author":"Dal Ben","year":"2014","journal-title":"Biochem. Pharmacol"},{"key":"10.1016\/j.ejmech.2021.113983_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000139033","article-title":"Structure-activity relationships for 2-substituted adenosines at A1 and A2 adenosine receptors","volume":"46","author":"Daly","year":"1993","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejmech.2021.113983_bib27","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/j.bcp.2004.06.011","article-title":"2-Substituted adenosine derivatives: affinity and efficacy at four subtypes of human adenosine receptors","volume":"68","author":"Gao","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113983_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s002109900044","article-title":"2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A3 adenosine receptors","volume":"360","author":"Klotz","year":"1999","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113983_bib29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bmcl.2006.09.065","article-title":"N6-Cycloalkyl-2-substituted adenosine derivatives as selective, high affinity adenosine A1 receptor agonists","volume":"17","author":"Elzein","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113983_bib30","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3390\/cells9061509","article-title":"The anti-inflammatory and pain-relieving effects of AR170, an adenosine A3 receptor agonist, in a rat model of colitis","volume":"9","author":"Antonioli","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2021.113983_bib31","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113983_bib32","doi-asserted-by":"crossref","first-page":"9901","DOI":"10.1021\/jm501021n","article-title":"In\u00a0vivo phenotypic screening for treating chronic neuropathic pain: modification of C2-arylethynyl group of conformationally constrained A3 adenosine receptor agonists","volume":"57","author":"Tosh","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113983_bib33","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1016\/j.bmcl.2008.04.001","article-title":"Design of (N)-methanocarba adenosine 5\u2032-uronamides as species-independent A3 receptor-selective agonists","volume":"18","author":"Melman","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113983_bib34","doi-asserted-by":"crossref","first-page":"7580","DOI":"10.1021\/jm900426g","article-title":"Functionalized congeners of A3 adenosine receptor selective nucleosides containing a bicyclo[3.1.0]hexane ring system","volume":"52","author":"Tosh","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113983_bib35","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1021\/acsmedchemlett.5b00150","article-title":"Rigidified A3 adenosine receptor agonists: 1-Deaza modification maintains high in\u00a0vivo efficacy","volume":"6","author":"Tosh","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113983_bib36","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.cell.2017.01.042","article-title":"Structure of the adenosine A1 receptor reveals the basis for subtype selectivity","volume":"168","author":"Glukhova","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ejmech.2021.113983_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175642","article-title":"Mini-G proteins: novel tools for studying GPCRs in their active conformation","volume":"12","author":"Nehm\u00e9","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2021.113983_bib38","doi-asserted-by":"crossref","first-page":"113934","DOI":"10.1016\/j.bcp.2020.113934","article-title":"Assessment of signaling bias at the A3 adenosine receptor using \u03b2-arrestin and miniG\u03b1i recruitment assays","volume":"117","author":"Pottie","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113983_bib39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bcp.2018.10.003","article-title":"Probing structure-activity relationship in \u03b2-arrestin2 recruitment of diversely substituted adenosine derivatives","volume":"158","author":"Storme","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113983_bib40","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nature11691","article-title":"Automated design of ligands to polypharmacological profiles","volume":"492","author":"Besnard","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113983_bib41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/jpet.120.000004","article-title":"Chronic morphine-induced changes in signaling at the A3 adenosine receptor contribute to morphine-induced hyperalgesia, tolerance and withdrawal","volume":"374","author":"Doyle","year":"2020","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"issue":"11","key":"10.1016\/j.ejmech.2021.113983_bib42","first-page":"1362","article-title":"Characterization of dextromethorphan O- and N-demethylation catalyzed by highly purified recombinant human CYP2D6","volume":"29","author":"Yu","year":"2001","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejmech.2021.113983_bib43","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11302-014-9409-4","article-title":"The role of activated adenosine receptors in degranulation of human LAD2 mast cells","volume":"10","author":"Leung","year":"2014","journal-title":"Purinergic Signal."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113983_bib44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11302-020-09694-2","article-title":"The belated US FDA approval of the adenosine A2A receptor antagonist istradefylline for treatment of Parkinson's disease","volume":"16","author":"Chen","year":"2020","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.ejmech.2021.113983_bib45","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1021\/acs.jmedchem.6b00653","article-title":"Controlling the dissociation of ligands from the adenosine A2A receptor through modulation of salt bridge strength","volume":"59","author":"Segala","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113983_bib46","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.bcp.2017.12.026","article-title":"A\u00a0binding kinetics study of human adenosine A3 receptor agonists","volume":"153","author":"Xia","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113983_bib47","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.bcp.2009.11.009","article-title":"Synthesis and pharmacological characterization of [125I]MRS5127, a high affinity, selective agonist radioligand for the A3 adenosine receptor","volume":"79","author":"Auchampach","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113983_bib48","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11302-008-9107-1","article-title":"Synthesis and pharmacological characterization of [125I]MRS1898, a high affinity, selective radioligand for the rat A3 adenosine receptor","volume":"5","author":"Gao","year":"2009","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.ejmech.2021.113983_bib49","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J.\u00a0Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2021.113983_bib50","series-title":"Schr\u00f6dinger Release 2020-1: Maestro","year":"2020"},{"key":"10.1016\/j.ejmech.2021.113983_bib51","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113983_bib52","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113983_bib53","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision Glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113983_bib54","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113983_bib55","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1021\/acs.jctc.6b00049","article-title":"HTMD: high-throughput molecular dynamics for molecular discovery","volume":"12","author":"Doerr","year":"2016","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2021.113983_bib56","doi-asserted-by":"crossref","first-page":"D370","DOI":"10.1093\/nar\/gkr703","article-title":"OPM database and PPM Web server: resources for positioning of proteins in membranes","volume":"40","author":"Lomize","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"33\u201338","key":"10.1016\/j.ejmech.2021.113983_bib57","first-page":"27","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J.\u00a0Mol. Graph."},{"key":"10.1016\/j.ejmech.2021.113983_bib58","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.ejmech.2021.113983_bib59","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1021\/ct9000685","article-title":"ACEMD: accelerating biomolecular dynamics in the microsecond time scale","volume":"5","author":"Harvey","year":"2009","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2021.113983_bib60","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1021\/ct300400x","article-title":"Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone \u03c6, \u03c8 and side-chain \u03c7(1) and \u03c7(2) dihedral angles","volume":"8","author":"Best","year":"2012","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2021.113983_bib61","doi-asserted-by":"crossref","first-page":"7830","DOI":"10.1021\/jp101759q","article-title":"Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types","volume":"114","author":"Klauda","year":"2010","journal-title":"J.\u00a0Phys. Chem. B"},{"key":"10.1016\/j.ejmech.2021.113983_bib62","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1021\/ci300363c","article-title":"Automation of the CHARMM general force field (CGenFF) I: bond perception and atom typing","volume":"52","author":"Vanommeslaeghe","year":"2012","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2021.113983_bib63","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1021\/ci3003649","article-title":"Automation of the CHARMM general force field (CGenFF) II: assignment of bonded parameters and partial atomic charges","volume":"52","author":"Vanommeslaeghe","year":"2012","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2021.113983_bib65","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1063\/1.470117","article-title":"A\u00a0smooth particle mesh Ewald method","volume":"103","author":"Essmann","year":"1995","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.ejmech.2021.113983_bib66","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/jcc.21688","article-title":"Wordom: a user-friendly program for the analysis of molecular structures, trajectories, and free energy surfaces","volume":"32","author":"Seeber","year":"2011","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2021.113983_bib67","series-title":"Proceedings of the 9th Python in Science Conference; Proceedings of the python in Science Conference","doi-asserted-by":"crossref","first-page":"56","DOI":"10.25080\/Majora-92bf1922-00a","article-title":"Data structures for statistical computing in python","author":"McKinney","year":"2010"},{"key":"10.1016\/j.ejmech.2021.113983_bib68","author":"Williams"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421008321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421008321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:02:04Z","timestamp":1777528924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421008321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":67,"alternative-id":["S0223523421008321"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113983","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A3 adenosine receptor agonists containing dopamine moieties for enhanced interspecies affinity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113983","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113983"}}